JAZZ Jazz Pharmaceuticals plc - Ordinary Shares
$256.92
株価 · 8月 19, 2026
ファンダメンタルズ（時点） 8月 3, 2026
52週レンジ
$118–$265
94% of range
アナリスト評価
BUY
26 analysts
目標株価
$281
+9% upside
P/E (TTM)
-29.1
ROE
—
純利益率
—
Jazz Pharmaceuticals plc - Ordinary Shares について Wikipediaからの企業概要
Jazz Pharmaceuticals plc is an American global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
続きを読む
Jazz Pharmaceuticals plc (a merger of Jazz Pharmaceuticals, Inc. and Azur Pharma plc) is an American global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
One of the company's considerable products is the United States Food and Drug Administration (FDA) approved drug Xyrem (sodium oxybate), the sodium salt of the naturally occurring neurotransmitter γ-Hydroxybutyric acid (GHB). In 2017, net product sales of Xyrem were $1.187 billion, which represented 74% of the company's total net product sales. In 2019, Jazz was granted FDA-approval to market Sunosi with indications for treating excessive daytime sleepiness (EDS) in narcolepsy as well as obstructive sleep apnea (OSA). In 2022, it was announced that Axsome Therapeutics would be acquiring Sunosi from Jazz Pharmaceuticals.
In 2007, the company pled guilty to felony charges related to its illegal marketing of Xyrem for off-label use.
The company is also a member of the Pharmaceutical Research and Manufacturers of America (PhRMA).
Company history and acquisitions
2010–2019
On 18 February 2010, the FDA accepted a new drug application for JZP-6 (Sodium oxybate) for the treatment of Fibromyalgia. In the following December, a new patent was issued for Sodium Oxybate.
On September 19, 2011, Jazz Pharmaceuticals merged with Irish Azur Pharma plc to form Jazz Pharmaceuticals plc. The Azur Pharma seat in Dublin became the headquarters of the combined company. Azur Pharma had been marketing specialty pharmaceutical products in the central nervous system (CNS) and women's health areas with US operations in Philadelphia.
On 26 April 2012, the company acquired EUSA Pharma for $650 million (plus $50 million in milestone payments). In September, the company sold its Women's Health business to Meda for $95 million. In December, the company began clinical trial of intravenous Erwinaze in patients with Acute Lymphoblastic Leukemia.
In January 2014, the company announced it would acquire the rare disease drug developer Gentium SpA and its lead product Defitelio for $1 billion.
In May 2016, the company announced it would acquire Alizé Pharma II for $20.5 million. At the end of the same month, the company announced its then largest acquisition, with the purchase of Celator Pharmaceuticals for $1.5 billion. As a result, Jazz obtained the rights to breakthrough therapy Vyxeos (liposomal daunorubicin and cytarabine) for treatment of acute myeloid leukemia.
In August 2019, the company announced it would acquire Cavion Inc. for up to $310 million.
2020–present
In January 2021, Jazz announced it would acquire cannabis-focused medicinal drug company GW Pharmaceuticals for US$7.2 billion. This acquisition added the medication Epidiolex (cannabidiol), developed to treat severe epilepsy syndromes, to the company's portfolio.
In November 2025, Jazz Pharmaceuticals announced positive results from its Phase 3 trial for its cancer drug, Ziihera, a potential treatment for advanced gastroesophageal cancer.
Acquisition history
The following is an illustration of the company's mergers, acquisitions, spin-offs and historical predecessors:
== References ==
出典: Wikipedia (英語), CC BY-SA 4.0 · Wikipediaで表示 ↗
JAZZ 株価スナップショット 価格、時価総額、P/E、EPS、ROE、負債/資本、52週レンジ
株価
$256.92
時価総額
—
P/E (TTM)
-29.1
EPS（TTM）
$-5.84
収益（TTM）
$4.27B
配当利回り
—
ROE
—
負債/自己資本
—
52週レンジ
$118 – $265
JAZZ 株価チャート 技術指標付きの日次 OHLCV — パン、ズーム、ビューのカスタマイズ
Configure
10年間のパフォーマンス 収益、純利益、利益率、EPSのトレンド
収益と純利益
$4.27B
2016-12-31
→
2025-12-31
EPS
$-5.84
2016-12-31
→
2025-12-31
フリーキャッシュフロー
—
利益率
—
バリュエーション P/E、P/S、P/B、EV/EBITDA比率 — 株は割高か割安か？
指標
5年トレンド
JAZZ
競合中央値
P/E (TTM)
-29.1
530.6
収益性 粗利益率、営業利益率、純利益率、ROE、ROA、ROIC
指標
5年トレンド
JAZZ
競合中央値
財務健全性 負債、流動性、支払能力 — バランスシートの健全性
指標
5年トレンド
JAZZ
競合中央値
成長 収益、EPS、純利益の成長率：前年比、3年CAGR、5年CAGR
指標
5年トレンド
JAZZ
競合中央値
Revenue YoY (収益（前年比）)
4.9%
—
Revenue CAGR 3Y (収益（3年CAGR）)
5.3%
—
Revenue CAGR 5Y (収益（5年CAGR）)
12.5%
—
EPS YoY
41.8%
—
Net Income YoY (純利益（前年比）)
35.0%
—
資本効率 総資産回転率、棚卸資産回転率、売掛金回転率
指標
5年トレンド
JAZZ
競合中央値
JAZZ アナリストコンセンサス 強気・弱気のアナリストの見解、12ヶ月の目標株価、アップサイド
買い
26 アナリスト
- 強い買い 7 26.9%
- 買い 17 65.4%
- 保有 2 7.7%
- 売り 0 0.0%
- 強い売り 0 0.0%
12ヶ月目標株価
20 アナリスト · 2026-08-15
中央値
$285.00
現在
$256.92
安値
$196.00
高値
$315.00
中央値ターゲット
$285.00
+10.9%
平均値ターゲット
$281.10
+9.4%
決算履歴 EPS実績 vs 予想、サプライズ%、達成率、次回決算日
平均サプライズ
-0.06%
| 期間 | EPS Actual | EPS 予想 | サプライズ |
|---|---|---|---|
| 2026年6月30日 | $5.71 | $6.30 | -0.59% |
| 2026年3月31日 | $6.34 | $4.66 | 1.7% |
| 2025年12月31日 | $6.64 | $6.65 | -0.01% |
| 2025年9月30日 | $8.13 | $6.04 | 2.1% |
| 2025年6月30日 | $-8.25 | $-7.76 | -0.49% |
| 2025年3月31日 | $1.68 | $4.75 | -3.1% |
同業他社比較（GICSサブインダストリー） 主要メトリクスとセクターピアの比較
| ティッカー | 時価総額 | P/E | 売上高 YoY | 純利益率 | ROE | 粗利益率 |
|---|---|---|---|---|---|---|
| JAZZ | — | -29.1 | 4.9% | — | — | — |
| GHRS | — | — | — | — | — | — |
| PRGO | $1.92B | -1.4 | -2.8% | -33.5% | -38.5% | 35.1% |
完全なファンダメンタルズ 年次別全指標 — 損益計算書、貸借対照表、キャッシュフロー
損益計算書 14
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.27B | $4.07B | $3.83B | $3.66B | $3.09B | $2.36B | $2.16B | $1.89B | $1.62B | $1.49B | $1.32B | $1.17B | |
| R&D Expense | · | · | · | · | · | · | $300M | $227M | $198M | $162M | $135M | $85M | |
| SG&A Expense | $1.81B | $1.39B | $1.34B | $1.42B | $1.45B | $854M | $737M | $684M | $544M | $503M | $449M | $406M | |
| Operating Expenses | $4.70B | $3.35B | $3.26B | $3.72B | $2.92B | $1.99B | $1.63B | $1.28B | $1.09B | $896M | $817M | $977M | |
| Operating Income | $-430M | $717M | $579M | $-66M | $170M | $378M | $532M | $615M | $529M | $592M | $508M | $196M | |
| Interest Income | $86M | $106M | $65M | $12M | $2M | $11M | $20M | $17M | $4M | · | · | · | |
| Other Non-op | · | · | · | · | · | · | · | · | · | · | $1M | $9M | |
| Pretax Income | $-628M | $470M | $298M | $-373M | $-113M | $275M | $454M | $529M | $441M | $532M | $436M | $152M | |
| Income Tax | $-272M | $-91M | $-120M | $-159M | $216M | $34M | $-73M | $80M | $-48M | $135M | $106M | $94M | |
| Net Income | $-356M | $560M | $415M | $-224M | $-330M | $239M | $523M | $447M | $488M | $397M | $330M | $58M | |
| EPS (Basic) | $-5.84 | $9.06 | $6.55 | $-3.58 | $-5.52 | $4.28 | $9.22 | $7.45 | $8.13 | $6.56 | $5.38 | $0.98 | |
| EPS (Diluted) | $-5.84 | $8.65 | $6.10 | $-3.58 | $-5.52 | $4.22 | $9.09 | $7.30 | $7.96 | $6.41 | $5.23 | $0.93 | |
| Shares (Basic) | 60,981,000 | 61,838,000 | 63,291,000 | 62,539,000 | 59,694,000 | 55,712,000 | 56,749,000 | 59,976,000 | 60,018,000 | 60,500,000 | 61,232,000 | 59,746,000 | |
| Shares (Diluted) | 60,981,000 | 66,007,000 | 72,066,000 | 62,539,000 | 59,694,000 | 56,517,000 | 57,550,000 | 61,221,000 | 61,317,000 | 61,870,000 | 63,036,000 | 62,614,000 |
貸借対照表 26
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.39B | $2.41B | $1.51B | $881M | $591M | $1.06B | $637M | $310M | $386M | $366M | $989M | $684M | |
| Receivables | $831M | $717M | $706M | $651M | $563M | $396M | $356M | $264M | $224M | $234M | $210M | $186M | |
| Inventory | $417M | $480M | $597M | $714M | $1.07B | $95M | $79M | $53M | $43M | $34M | $19M | $30M | |
| Prepaid Expense | $152M | $177M | $185M | $92M | $131M | $62M | $39M | $25M | $23M | $25M | $21M | $13M | |
| Other Current Assets | $324M | $262M | $321M | $267M | $252M | $152M | $79M | $68M | $77M | $29M | $19M | $21M | |
| Current Assets | $4.17B | $4.63B | $3.44B | $2.61B | $2.61B | $2.84B | $1.63B | $1.23B | $968M | $748M | $1.26B | $1.02B | |
| PP&E (Net) | · | · | · | · | · | $128M | $132M | $200M | $170M | $107M | $86M | $58M | |
| PP&E (Gross) | · | · | · | · | · | $196M | $187M | $250M | $211M | $140M | $109M | $74M | |
| Accum. Depreciation | · | · | · | · | · | $68M | $55M | $50M | $41M | $32M | $24M | $15M | |
| Goodwill | $1.83B | $1.72B | $1.75B | $1.69B | $1.83B | $958M | $920M | $928M | $948M | $894M | $657M | $703M | |
| Intangibles | $4.43B | $4.76B | $5.42B | $5.79B | $7.15B | $2.20B | $2.44B | $2.73B | $2.98B | $3.01B | $1.19B | $1.44B | |
| Other Non-current Assets | $99M | $114M | $67M | $55M | $41M | $26M | $48M | $43M | $16M | $14M | $9M | $16M | |
| Total Assets | $11.66B | $12.01B | $11.39B | $10.84B | $12.30B | $6.54B | $5.54B | $5.20B | $5.12B | $4.80B | $3.33B | $3.34B | |
| Accounts Payable | $122M | $78M | $103M | $91M | $100M | $27M | $46M | $41M | $24M | $22M | $22M | $25M | |
| Accrued Liabilities | $1.03B | $911M | $794M | $803M | $666M | $353M | $270M | $265M | $199M | $193M | $164M | $164M | |
| Current Liabilities | $2.24B | $1.04B | $1.54B | $933M | $809M | $654M | $364M | $345M | $294M | $257M | $227M | $217M | |
| Capital Leases | $51M | $39M | $59M | $72M | $87M | $140M | $151M | $0 | · | · | · | · | |
| Deferred Tax | $594M | $677M | $848M | $944M | $1.30B | $130M | $224M | $309M | $383M | $557M | $283M | $375M | |
| Other Non-current Liabilities | $124M | $87M | $105M | $107M | $117M | $101M | $109M | $219M | $177M | $113M | $69M | $38M | |
| Long-term Debt | $5.36B | $6.11B | $5.71B | $5.72B | $6.05B | $2.09B | $1.61B | $1.60B | $1.58B | $2.03B | $1.19B | $1.34B | |
| Common Stock | $0 | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | |
| Retained Earnings | $646M | $1.13B | $879M | $734M | $830M | $1.16B | $1.07B | $841M | $918M | $529M | $303M | $35M | |
| AOCI | $-569M | $-948M | $-842M | $-1.13B | $-400M | $-134M | $-223M | $-198M | $-141M | $-317M | $-267M | $-122M | |
| Stockholders' Equity | $4.32B | $4.09B | $3.74B | $3.09B | $3.97B | $3.66B | $3.11B | $2.76B | $2.71B | $1.88B | $1.71B | $1.37B | |
| Liabilities + Equity | $11.66B | $12.01B | $11.39B | $10.84B | $12.30B | $6.54B | $5.54B | $5.20B | $5.12B | $4.80B | $3.33B | $3.34B | |
| Shares Outstanding | 61,400,000 | 60,600,000 | 62,255,000 | 63,214,000 | 61,633,000 | 56,171,000 | 56,140,000 | 57,704,000 | 58,898,000 | 59,820,000 | 61,305,000 | 60,643,000 |
キャッシュフロー 12
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $42M | $33M | $30M | $30M | $27M | $19M | $15M | $15M | $13M | $12M | $10M | · | |
| Stock-based Comp | $291M | $248M | $227M | $222M | $189M | $121M | $111M | $102M | $107M | $99M | $92M | $70M | |
| Deferred Tax | $-445M | $-208M | $-260M | $-292M | $69M | $-137M | $-237M | $-89M | $-226M | $-41M | $-68M | $-49M | |
| Amort. of Intangibles | $655M | $627M | $608M | $599M | $526M | $260M | $355M | $201M | $152M | $102M | $98M | $127M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | $2M | $2M | |
| Operating Cash Flow | $1.36B | $1.40B | $1.09B | $1.27B | $779M | $900M | $776M | $799M | $693M | $592M | $532M | $408M | |
| CapEx | $59M | $38M | $24M | $29M | $28M | $15M | $40M | $20M | $29M | $10M | $36M | $36M | |
| Investing Cash Flow | $-1.51B | $-508M | $-163M | $-446M | $-5.21B | $-1.01B | $-155M | $-394M | $-269M | $-1.75B | $-2M | $-1.07B | |
| Stock Repurchased | $125M | $311M | $270M | $54.0K | $0 | $147M | $301M | $524M | $99M | $278M | $62M | $42M | |
| Financing Cash Flow | $-873M | $21M | $-305M | $-529M | $3.97B | $528M | $-294M | $-479M | $-409M | $541M | $-214M | $711M | |
| Net Change in Cash | $-1.02B | $907M | $625M | $290M | $-466M | $420M | $328M | $-76M | $20M | $-623M | $305M | $48M | |
| Taxes Paid | $122M | $115M | $178M | · | · | · | · | · | · | · | · | · |
成長率 7
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 4.9% | 6.1% | 4.8% | 18.3% | 30.9% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 5.3% | 9.6% | 17.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 12.5% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | 41.8% | · | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | · | 13.1% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | 35.0% | · | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | · | 20.2% | · | · | · | · | · | · | · | · | · |
バリュエーション（TTM） 5
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.27B | $4.07B | $3.83B | $3.66B | $3.09B | $2.36B | $2.16B | $1.89B | $1.62B | $1.49B | $1.32B | $1.17B | |
| Net Income TTM | $-356M | $560M | $415M | $-224M | $-330M | $239M | $523M | $447M | $488M | $397M | $330M | $58M | |
| P/E | -29.1 | 14.2 | 20.2 | -44.5 | -23.1 | 39.1 | 16.4 | 17.0 | 16.9 | 17.0 | 26.9 | 176.1 | |
| P / Tangible Book | · | · | · | · | · | 18.3 | · | · | · | · | · | · | |
| Earnings Yield | -3.4% | 7.0% | 5.0% | -2.2% | -4.3% | 2.6% | 6.1% | 5.9% | 5.9% | 5.9% | 3.7% | 0.57% |
損益計算書 13
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.21B | $1.07B | $1.20B | $1.13B | $1.05B | $898M | $1.09B | $1.05B | $1.02B | $902M | $1.01B | $972M | $957M | $893M | $972M | $941M | |
| SG&A Expense | $389M | $353M | $406M | $531M | $358M | $514M | $369M | $326M | $339M | $352M | $396M | $308M | $341M | $298M | $383M | $358M | |
| Operating Expenses | $960M | $732M | $943M | $1.07B | $1.73B | $954M | $897M | $795M | $824M | $836M | $889M | $800M | $800M | $767M | $1.24B | $916M | |
| Operating Income | $248M | $337M | $255M | $58M | $-686M | $-56M | $191M | $260M | $199M | $66M | $122M | $172M | $158M | $126M | $-263M | $25M | |
| Interest Income | $25M | $23M | $20M | $19M | $19M | $28M | $32M | $26M | $25M | $23M | $21M | $19M | $15M | $11M | $7M | $4M | |
| Pretax Income | $211M | $299M | $208M | $9M | $-736M | $-110M | $133M | $201M | $138M | $-2M | $62M | $100M | $82M | $55M | $-340M | $-60M | |
| Income Tax | $18M | $6M | $5M | $-242M | $-17M | $-18M | $-58M | $-15M | $-31M | $12M | $-33M | $-47M | $-24M | $-15M | $-100M | $-43M | |
| Net Income | $193M | $293M | $203M | $251M | $-718M | $-92M | $191M | $215M | $169M | $-15M | $94M | $147M | $104M | $69M | $-241M | $-20M | |
| EPS (Basic) | $3.05 | $4.73 | $3.28 | $4.14 | $-11.74 | $-1.52 | $3.11 | $3.50 | $2.68 | $-0.23 | $1.50 | $2.33 | $1.63 | $1.09 | $-3.86 | $-0.31 | |
| EPS (Diluted) | $2.78 | $4.43 | $3.34 | $4.08 | $-11.74 | $-1.52 | $2.97 | $3.42 | $2.49 | $-0.23 | $1.40 | $2.14 | $1.52 | $1.04 | $-3.85 | $-0.31 | |
| Shares (Basic) | 63,200,000 | 61,900,000 | -121,888,000 | 60,696,000 | 61,200,000 | 61,000,000 | -124,995,000 | 61,414,000 | 62,882,000 | 62,537,000 | -127,308,000 | 63,114,000 | 63,991,000 | 63,494,000 | -124,547,000 | 62,785,000 | |
| Shares (Diluted) | 69,400,000 | 66,100,000 | -122,798,000 | 61,606,000 | 61,200,000 | 61,000,000 | -129,329,000 | 63,174,000 | 69,625,000 | 62,537,000 | -146,538,000 | 71,293,000 | 73,540,000 | 73,771,000 | -126,584,000 | 62,785,000 | |
| EBITDA | $248M | $337M | · | $58M | $-686M | $-56M | · | $260M | $199M | $66M | · | $172M | $158M | $126M | · | $25M |
貸借対照表 24
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.62B | $1.84B | $1.39B | $1.33B | $1.19B | $1.86B | $2.41B | $2.22B | $1.36B | $1.44B | · | $1.34B | $1.28B | $1.17B | · | $839M | |
| Receivables | $881M | $836M | $831M | $764M | $714M | $653M | $717M | $724M | $698M | $707M | · | $628M | $610M | $624M | · | $601M | |
| Inventory | $443M | $438M | $417M | $483M | $505M | $493M | $480M | $539M | $543M | $577M | · | $612M | $657M | $675M | · | $728M | |
| Prepaid Expense | $200M | $150M | $152M | $147M | $164M | $150M | $177M | $155M | $134M | $123M | · | $110M | $107M | $73M | · | $93M | |
| Other Current Assets | $244M | $285M | $324M | $315M | $298M | $260M | $262M | $354M | $326M | $315M | · | $310M | $272M | $245M | · | $250M | |
| Current Assets | $3.97B | $4.58B | $4.17B | $3.76B | $3.35B | $4.13B | $4.63B | $4.39B | $3.68B | $3.54B | · | $3.25B | $3.01B | $2.78B | · | $2.57B | |
| Goodwill | $1.80B | $1.80B | $1.83B | $1.83B | $1.84B | $1.76B | $1.72B | $1.80B | $1.74B | $1.74B | · | $1.71B | $1.74B | $1.72B | · | $1.59B | |
| Intangibles | $4.03B | $4.20B | $4.43B | $4.57B | $4.77B | $4.72B | $4.76B | $5.14B | $5.08B | $5.24B | · | $5.42B | $5.71B | $5.76B | · | $5.57B | |
| Other Non-current Assets | $86M | $95M | $99M | $103M | $121M | $117M | $114M | $75M | $71M | $71M | · | $76M | $66M | $64M | · | $35M | |
| Total Assets | $11.08B | $11.86B | $11.66B | $11.36B | $10.94B | $11.53B | $12.01B | $12.26B | $11.36B | $11.33B | · | $11.20B | $11.26B | $11.05B | · | $10.38B | |
| Accounts Payable | $128M | $100M | $122M | $152M | $89M | $96M | $78M | $85M | $97M | $81M | · | $110M | $98M | $125M | · | $102M | |
| Accrued Liabilities | $1.03B | $1.02B | $1.03B | $1.00B | $875M | $1.06B | $911M | $859M | $801M | $827M | · | $770M | $748M | $712M | · | $668M | |
| Current Liabilities | $2.23B | $2.25B | $2.24B | $2.27B | $2.07B | $1.22B | $1.04B | $1.03B | $1.56B | $1.56B | · | $1.57B | $945M | $909M | · | $813M | |
| Capital Leases | $44M | $47M | $51M | $53M | $55M | $39M | $39M | $71M | $68M | $56M | · | $62M | $66M | $72M | · | $73M | |
| Deferred Tax | $529M | $548M | $594M | $629M | $682M | $671M | $677M | $792M | $775M | $810M | · | $841M | $911M | $932M | · | $934M | |
| Other Non-current Liabilities | $141M | $162M | $125M | $109M | $94M | $91M | $87M | $111M | $99M | $97M | · | $127M | $127M | $109M | · | $124M | |
| Long-term Debt | $4.35B | $5.35B | $5.36B | $5.36B | $5.36B | $5.37B | $6.11B | $6.11B | $5.71B | $5.71B | · | $5.72B | $5.72B | $5.72B | · | $5.73B | |
| Total Debt | $4.35B | $5.35B | · | $5.36B | $5.36B | $5.37B | · | $6.11B | $5.71B | $5.71B | · | $5.72B | $5.72B | $5.72B | · | $5.73B | |
| Common Stock | $0 | $0 | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | · | $6.0K | $6.0K | $6.0K | · | $6.0K | |
| Retained Earnings | $1.13B | $939M | $646M | $443M | $191M | $1.03B | $1.13B | $936M | $871M | $864M | · | $884M | $812M | $803M | · | $974M | |
| AOCI | $-662M | $-651M | $-569M | $-570M | $-486M | $-786M | $-948M | $-603M | $-888M | $-882M | · | $-1.04B | $-867M | $-980M | · | $-1.62B | |
| Stockholders' Equity | $4.80B | $4.53B | $4.32B | $3.96B | $3.71B | $4.17B | $4.09B | $4.17B | $3.76B | $3.70B | $3.74B | $3.49B | $3.53B | $3.34B | $3.09B | $2.75B | |
| Liabilities + Equity | $11.08B | $11.86B | $11.66B | $11.36B | $10.94B | $11.53B | $12.01B | $12.26B | $11.36B | $11.33B | · | $11.20B | $11.26B | $11.05B | · | $10.38B | |
| Shares Outstanding | 64,800,000 | 62,700,000 | 61,435,000 | 60,740,000 | 60,640,000 | 61,623,000 | 60,631,000 | 60,443,000 | 61,745,000 | 63,028,000 | 62,255,000 | 62,945,000 | · | · | 63,214,000 | · |
キャッシュフロー 10
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $73M | $74M | $71M | $88M | $65M | $68M | $70M | $60M | $57M | $61M | $53M | $56M | $61M | $56M | $62M | $57M | |
| Deferred Tax | $-39M | $-66M | $-63M | $-271M | $-66M | $-44M | $-2M | $-64M | $-75M | $-66M | $-36M | $-79M | $-79M | $-66M | $-145M | $-65M | |
| Amort. of Intangibles | $170M | $172M | $170M | $168M | $162M | $154M | $159M | $157M | $155M | $156M | $152M | $155M | $152M | $150M | $137M | $141M | |
| Operating Cash Flow | $416M | $408M | $363M | $475M | $89M | $430M | $399M | $399M | $331M | $267M | $167M | $307M | $297M | $321M | $342M | $418M | |
| CapEx | $18M | $20M | $17M | $15M | $13M | $14M | $13M | $11M | $7M | $7M | $10M | $4M | $6M | $4M | $9M | $-5M | |
| Investing Cash Flow | $355M | $123M | $-372M | $-328M | $-641M | $-169M | $-193M | $214M | $-257M | $-272M | $102M | $-174M | $-86M | $-5M | $-324M | $5M | |
| Stock Repurchased | · | · | $0 | $0 | · | · | $0 | $150M | · | · | $100M | $74M | · | · | $0 | $0 | |
| Financing Cash Flow | $-994M | $-78M | $75M | $-11M | $-125M | $-814M | $-8M | $246M | $-161M | $-57M | $-100M | $-78M | $-97M | $-30M | $20M | $-289M | |
| Net Change in Cash | $-224M | $452M | $66M | $136M | $-672M | $-551M | $195M | $862M | $-88M | $-63M | $171M | $53M | $114M | $286M | $42M | $128M | |
| Free Cash Flow | · | $388M | · | · | · | $416M | · | · | · | $260M | · | · | · | $317M | · | · |
収益性 7
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 20.5% | 31.5% | · | 5.1% | -65.6% | -6.2% | · | 24.7% | 19.5% | 7.3% | · | 17.7% | 16.5% | 14.1% | · | 2.6% | |
| Net Margin | 16.0% | 27.4% | · | 22.3% | -68.7% | -10.3% | · | 20.4% | 16.5% | -1.6% | · | 15.1% | 10.9% | 7.8% | · | -2.1% | |
| Pretax Margin | 17.5% | 28.0% | · | 0.80% | -70.3% | -12.2% | · | 19.0% | 13.5% | -0.18% | · | 10.2% | 8.5% | 6.2% | · | -6.4% | |
| EBITDA Margin | 20.5% | 31.5% | · | 5.1% | -65.6% | -6.2% | · | 24.7% | 19.5% | 7.3% | · | 17.7% | 16.5% | 14.1% | · | 2.6% | |
| ROA | 1.8% | 2.5% | · | 2.1% | -6.4% | -0.81% | · | 1.8% | 1.5% | -0.13% | · | 1.4% | 0.93% | 0.61% | · | -0.17% | |
| ROE | 4.5% | 6.7% | · | 6.2% | -19.2% | -2.4% | · | 5.6% | 4.6% | -0.42% | · | 4.7% | 3.1% | 2.0% | · | -0.59% | |
| ROIC | 2.5% | 3.3% | · | 17.2% | -7.4% | -0.49% | · | 2.7% | 2.6% | 5.8% | · | 2.8% | 2.2% | 1.8% | · | 0.08% |
流動性と支払能力 4
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | 2.0 | · | 1.7 | 1.6 | 3.4 | · | 4.3 | 2.4 | 2.3 | · | 2.1 | 3.2 | 3.1 | · | 3.2 | |
| Quick Ratio | 1.1 | 1.2 | · | 0.9 | 0.9 | 2.1 | · | 2.9 | 1.3 | 1.4 | · | 1.2 | 2.0 | 2.0 | · | 1.8 | |
| Debt / Equity | 0.9 | 1.2 | · | 1.4 | 1.4 | 1.3 | · | 1.5 | 1.5 | 1.5 | · | 1.6 | 1.6 | 1.7 | · | 2.1 | |
| LT Debt / Equity | 0.7 | 1.0 | · | 1.1 | 1.2 | 1.3 | · | 1.5 | 1.4 | 1.4 | · | 1.5 | 1.6 | 1.7 | · | 2.1 |
効率性 2
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | 1.5 | 1.4 | · | 1.5 | 1.5 | 1.3 | · | 1.6 | 1.6 | 1.4 | · | 1.6 | 1.6 | 1.5 | · | 1.7 |
バリュエーション（TTM） 13
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.45B | $4.14B | · | $4.12B | $4.02B | $3.88B | · | $3.95B | $3.86B | $3.72B | · | $3.76B | $3.72B | $3.58B | · | $3.53B | |
| Net Income TTM | $19M | $-266M | · | $-345M | $-427M | $276M | · | $516M | $405M | $306M | · | $301M | $189M | $86M | · | $-36M | |
| Market Cap | $15.61B | $11.85B | · | $8.01B | $6.44B | $7.65B | · | $6.73B | $6.59B | $7.59B | · | $8.15B | · | · | · | · | |
| Enterprise Value | $18.35B | $15.36B | · | $12.04B | $10.61B | $11.16B | · | $10.63B | $10.94B | $11.86B | · | $12.53B | · | · | · | · | |
| P/E | -535.5 | -39.8 | · | -22.9 | -14.4 | 29.8 | · | 14.2 | 18.0 | 26.9 | · | 29.5 | 44.3 | 111.7 | · | -225.9 | |
| P/S | 3.5 | 2.9 | · | 1.9 | 1.6 | 2.0 | · | 1.7 | 1.7 | 2.0 | · | 2.2 | · | · | · | · | |
| P/B | 3.3 | 2.6 | · | 2.0 | 1.7 | 1.8 | · | 1.6 | 1.8 | 2.1 | · | 2.3 | · | · | · | · | |
| P / Cash Flow | · | 29.0 | · | · | · | 17.8 | · | · | · | 28.4 | · | · | · | · | · | · | |
| P / FCF | · | 30.5 | · | · | · | 18.4 | · | · | · | 29.2 | · | · | · | · | · | · | |
| EV / EBITDA | 73.9 | 45.6 | · | 209.4 | -15.5 | -199.6 | · | 40.8 | 54.9 | 179.1 | · | 72.7 | · | · | · | · | |
| EV / FCF | · | 39.5 | · | · | · | 26.8 | · | · | · | 45.5 | · | · | · | · | · | · | |
| EV / Revenue | 4.1 | 3.7 | · | 2.9 | 2.6 | 2.9 | · | 2.7 | 2.8 | 3.2 | · | 3.3 | · | · | · | · | |
| Earnings Yield | -0.19% | -2.5% | · | -4.4% | -6.9% | 3.4% | · | 7.0% | 5.5% | 3.7% | · | 3.4% | 2.3% | 0.90% | · | -0.44% |
財務諸表 損益計算書、貸借対照表、キャッシュフロー — 年次、過去5年間
損益計算書
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 収益 | $4.27B | $4.07B | $3.83B | $3.66B | $3.09B |
| 純利益 | $-356M | $560M | $415M | $-224M | $-330M |
| 希薄化後EPS | $-5.84 | $8.65 | $6.10 | $-3.58 | $-5.52 |
最新ニュース この会社に言及した最近の見出し
マイ指標 あなた専用のウォッチリスト — 決算詳細から選択した行
📊
あなたにとって重要なメトリクスを選択 — 上記の決算詳細の任意の行の横にある➕をクリックしてください。
選択内容は保存され、すべてのティッカーで引き継がれます。
機関投資家（13F） 690 提出者 · $9.8B合計 · 時点 2026年6月30日
四半期SECフォーム13Fでこの株式の保有を報告している機関。ロングポジションのみ。単一の提出者は、別々のオプションレッグで2回表示される場合があります。 大きな反対売買のプット/コール・レッグは、通常、マーケットメイクまたはヘッジされた在庫を反映しており、方向性への確信を示すものではありません。
機関投資家の動向 — Q2 2026 対 前四半期
| 新規ポジション | 解消済みポジション | 増加 | 減少 | 純株式数増減 |
|---|---|---|---|---|
| 143 (+46 前期比) | 56 (-21 前期比) | 220 (+20 前期比) | 190 (+12 前期比) | +4.4M |
Q1 2026と比較しました。 SECフォーム13Fの提出期限は四半期末から45日後ですが、遅延提出者向けの短いバッファーが含まれます。この期間内の四半期は、直近で完全に報告されたペアを優先するためスキップされます。
| 機関投資家 | 評価額 | 株式数 | % 追跡された13Fのうち | タイプ |
|---|---|---|---|---|
| FMR LLC | $846,470,147 | 3,512,762 | 8.60% | 株式数 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $731,636,247 | 3,036,213 | 7.43% | 株式数 |
| VANGUARD CAPITAL MANAGEMENT LLC | $657,763,761 | 2,729,650 | 6.68% | 株式数 |
| Capital World Investors | $650,043,082 | 2,697,610 | 6.60% | 株式数 |
| STATE STREET CORP | $481,895,662 | 1,999,816 | 4.89% | 株式数 |
| FULLER & THALER ASSET MANAGEMENT, INC. | $394,839,917 | 1,638,544 | 4.01% | 株式数 |
| DIMENSIONAL FUND ADVISORS LP | $390,196,222 | 1,619,274 | 3.96% | 株式数 |
| GEODE CAPITAL MANAGEMENT, LLC | $297,928,728 | 1,236,065 | 3.03% | 株式数 |
| AMERIPRISE FINANCIAL INC | $260,580,996 | 1,081,421 | 2.65% | 株式数 |
| CITADEL ADVISORS LLC | $242,578,716 | 1,006,676 | 2.46% | 株式数 |
| Swedbank AB | $233,208,837 | 967,792 | 2.37% | 株式数 |
| MILLENNIUM MANAGEMENT LLC | $184,072,164 | 763,880 | 1.87% | 株式数 |
| VICTORY CAPITAL MANAGEMENT INC | $165,478,678 | 686,719 | 1.68% | 株式数 |
| NORGES BANK | $158,279,458 | 656,843 | 1.61% | 株式数 |
| RENAISSANCE TECHNOLOGIES LLC | $135,442,731 | 562,073 | 1.38% | 株式数 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $129,891,746 | 539,037 | 1.32% | 株式数 |
| Allianz Asset Management GmbH | $122,925,785 | 510,129 | 1.25% | 株式数 |
| GMT Capital Corp | $109,279,895 | 453,500 | 1.11% | 株式数 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $105,278,106 | 436,893 | 1.07% | 株式数 |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $103,893,734 | 431,148 | 1.06% | 株式数 |
| TWO SIGMA INVESTMENTS, LP | $96,439,086 | 400,212 | 0.98% | 株式数 |
| VANGUARD FIDUCIARY TRUST CO | $95,008,929 | 394,277 | 0.96% | 株式数 |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | $89,279,867 | 370,502 | 0.91% | 株式数 |
| Sofinnova Investments, Inc. | $88,036,221 | 365,341 | 0.89% | 株式数 |
| Polaris Capital Management, LLC | $79,270,937 | 328,966 | 0.81% | 株式数 |
| AMERICAN CENTURY COMPANIES INC | $77,695,234 | 322,427 | 0.79% | 株式数 |
| Bank of New York Mellon Corp | $76,961,481 | 319,382 | 0.78% | 株式数 |
| GOLDENTREE ASSET MANAGEMENT LP | $70,838,675 | 294,435 | 0.72% | 株式数 |
| Qube Research & Technologies Ltd | $70,056,003 | 290,725 | 0.71% | 株式数 |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $66,815,854 | 277,279 | 0.68% | 株式数 |
| Quantinno Capital Management LP | $65,906,960 | 273,506 | 0.67% | 株式数 |
| Boston Trust Walden Corp | $64,110,068 | 266,050 | 0.65% | 株式数 |
| BANK OF AMERICA CORP /DE/ | $60,589,497 | 251,440 | 0.62% | 株式数 |
| Tri Locum Partners LP | $53,427,868 | 221,720 | 0.54% | 株式数 |
| Iron Triangle Partners LP | $49,668,900 | 292,170 | 0.50% | 株式数 |
| ARGENT CAPITAL MANAGEMENT LLC | $48,211,350 | 200,072 | 0.49% | 株式数 |
| GOLDMAN SACHS GROUP INC | $45,527,185 | 188,933 | 0.46% | 株式数 |
| PERCEPTIVE ADVISORS LLC | $40,964,900 | 170,000 | 0.42% | 株式数 |
| RAYMOND JAMES FINANCIAL INC | $39,434,259 | 163,648 | 0.40% | 株式数 |
| RHUMBLINE ADVISERS | $39,282,382 | 163,018 | 0.40% | 株式数 |
| Holocene Advisors, LP | $38,794,001 | 160,991 | 0.39% | 株式数 |
| Saturn V Capital Management LP | $38,781,230 | 160,938 | 0.39% | 株式数 |
| PFM Health Sciences, LP | $38,740,265 | 160,768 | 0.39% | 株式数 |
| Retirement Systems of Alabama | $38,473,993 | 159,663 | 0.39% | 株式数 |
| Woodline Partners LP | $36,165,501 | 150,083 | 0.37% | 株式数 |
| LOOMIS SAYLES & CO L P | $35,355,338 | 146,721 | 0.36% | 株式数 |
| Pictet Asset Management Holding SA | $35,115,175 | 147,599 | 0.36% | 株式数 |
| PRINCIPAL FINANCIAL GROUP INC | $34,163,762 | 141,776 | 0.35% | 株式数 |
| STIFEL FINANCIAL CORP | $33,583,066 | 139,365 | 0.34% | 株式数 |
| BNP PARIBAS FINANCIAL MARKETS | $33,026,625 | 137,057 | 0.34% | 株式数 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $32,383,478 | 134,388 | 0.33% | 株式数 |
| California Public Employees Retirement System | $30,759,098 | 127,647 | 0.31% | 株式数 |
| WEDGE CAPITAL MANAGEMENT L L P/NC | $30,249,134 | 160,006 | 0.31% | 株式数 |
| Robeco Institutional Asset Management B.V. | $28,340,967 | 117,612 | 0.29% | 株式数 |
| Gotham Asset Management, LLC | $26,992,014 | 112,014 | 0.27% | 株式数 |
| Aristotle Capital Management, LLC | $26,915,626 | 111,697 | 0.27% | 株式数 |
| Swiss National Bank | $26,771,767 | 111,100 | 0.27% | 株式数 |
| STOREBRAND ASSET MANAGEMENT AS | $26,309,828 | 109,183 | 0.27% | 株式数 |
| CANADA PENSION PLAN INVESTMENT BOARD | $25,928,372 | 107,600 | 0.26% | 株式数 |
| PANAGORA ASSET MANAGEMENT INC | $25,286,187 | 104,935 | 0.26% | 株式数 |
| BlackRock, Inc. | $23,889,284 | 99,138 | 0.24% | 株式数 |
| Perpetual Ltd | $23,733,376 | 98,491 | 0.24% | 株式数 |
| WELLINGTON MANAGEMENT GROUP LLP | $23,658,917 | 98,182 | 0.24% | 株式数 |
| MORGAN STANLEY | $23,519,795 | 97,604 | 0.24% | 株式数 |
| Man Group plc | $23,299,389 | 96,690 | 0.24% | 株式数 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $22,868,053 | 94,900 | 0.23% | プットオプション |
| ENVESTNET ASSET MANAGEMENT INC | $22,061,835 | 91,554 | 0.22% | 株式数 |
| Rhenman & Partners Asset Management AB | $21,070,417 | 87,440 | 0.21% | 株式数 |
| Aberdeen Group plc | $20,146,538 | 83,606 | 0.20% | 株式数 |
| Amundi | $19,114,464 | 79,323 | 0.19% | 株式数 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $18,916,145 | 78,500 | 0.19% | コールオプション |
| Schonfeld Strategic Advisors LLC | $18,620,232 | 77,272 | 0.19% | 株式数 |
| FIRST TRUST ADVISORS LP | $18,149,860 | 75,320 | 0.18% | 株式数 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $17,765,513 | 73,725 | 0.18% | 株式数 |
| LAZARD ASSET MANAGEMENT LLC | $16,768,620 | 69,588 | 0.17% | 株式数 |
| Longaeva Partners L.P. | $16,576,808 | 68,792 | 0.17% | 株式数 |
| Simplify Asset Management Inc. | $16,520,903 | 68,560 | 0.17% | 株式数 |
| ALLIANCEBERNSTEIN L.P. | $16,497,448 | 87,265 | 0.17% | 株式数 |
| Distillate Capital Partners LLC | $16,167,159 | 67,092 | 0.16% | 株式数 |
| SEB Asset Management AB | $15,890,255 | 65,943 | 0.16% | 株式数 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $15,380,484 | 64,700 | 0.16% | 株式数 |
| SEI INVESTMENTS CO | $14,931,224 | 61,963 | 0.15% | 株式数 |
| Illinois Municipal Retirement Fund | $14,911,947 | 61,883 | 0.15% | 株式数 |
| Tweedy, Browne Co LLC | $14,494,105 | 60,149 | 0.15% | 株式数 |
| MARTINGALE ASSET MANAGEMENT L P | $14,335,788 | 59,492 | 0.15% | 株式数 |
| DeepCurrents Investment Group LLC | $14,132,168 | 58,647 | 0.14% | 株式数 |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $13,348,774 | 55,396 | 0.14% | 株式数 |
| VANGUARD ASSET MANAGEMENT, Ltd | $12,952,138 | 53,750 | 0.13% | 株式数 |
| ExodusPoint Capital Management, LP | $12,819,845 | 53,201 | 0.13% | 株式数 |
| Squarepoint Ops LLC | $12,807,074 | 53,148 | 0.13% | 株式数 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $12,034,356 | 63,657 | 0.12% | 株式数 |
| ALGERT GLOBAL LLC | $11,749,697 | 48,760 | 0.12% | 株式数 |
| CASTLEARK MANAGEMENT LLC | $11,306,312 | 46,920 | 0.11% | 株式数 |
| CITADEL ADVISORS LLC | $11,253,299 | 46,700 | 0.11% | コールオプション |
| RENAISSANCE GROUP LLC | $11,221,601 | 46,568 | 0.11% | 株式数 |
| Nuveen, LLC | $11,184,623 | 46,415 | 0.11% | 株式数 |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $10,859,795 | 45,067 | 0.11% | 株式数 |
| Foundry Partners, LLC | $10,730,160 | 86,429 | 0.11% | 株式数 |
| Legal & General Group Plc | $10,402,916 | 43,171 | 0.11% | 株式数 |
| DEAN INVESTMENT ASSOCIATES, LLC | $10,273,274 | 42,633 | 0.10% | 株式数 |
企業インサイダー 50 人のインサイダー · 4人の役員 · 4人の取締役
| インサイダー | 役職 | 最終アクティビティ | 保有株式数 | 12ヶ月購入 | 12ヶ月売却 | 12ヶ月純額 |
|---|---|---|---|---|---|---|
| Renee D Gala | President & CEO | 2026年6月30日 F | 147,361 | 0 | 0 | $0 |
| Philip L Johnson | EVP & Chief Financial Officer | 2026年6月30日 F | 56,431 | 0 | 0 | $0 |
| Neena M Patil | EVP & Chief Legal Officer | 2026年6月30日 F | 48,871 | 0 | 2 | $-560,664 |
| Robert Iannone | EVP, Global Head of R&D & CMO | 2026年6月30日 F | 85,107 | 0 | 0 | $0 |
| Bryan C Cressey | 取締役 | 2012年3月9日 S | 27,631 | 0 | 0 | $0 |
| Zilkha M Nathaniel | 取締役 | 2011年3月10日 A | — | 0 | 0 | $0 |
| Alexander E Albert | 取締役 | 2008年8月15日 A | — | 0 | 0 | $0 |
| Patel Jaimin | 取締役 | 2007年8月15日 A | — | 0 | 0 | $0 |
| Patrick Kennedy | — | 2026年8月5日 A | 8,307 | 0 | 0 | $0 |
| Samantha Pearce | — | 2026年8月5日 F | 47,131 | 0 | 1 | $-1,625,977 |
| Mark Douglas Smith | — | 2026年8月5日 A | 11,285 | 0 | 1 | $-266,746 |
| Jennifer E. Cook | — | 2026年8月5日 A | 12,442 | 0 | 0 | $0 |
| Laura Hamill | — | 2026年8月5日 A | 8,538 | 0 | 0 | $0 |
| Heather Ann Mcsharry | — | 2026年8月5日 A | 20,054 | 0 | 0 | $0 |
| Seamus Mulligan | — | 2026年8月5日 A | 1,184,633 | 0 | 0 | $0 |
| Rick E Winningham | — | 2026年8月5日 A | 11,172 | 0 | 2 | $-1,656,873 |
| Patrick G. Enright | — | 2026年8月5日 A | 22,984 | 0 | 0 | $0 |
| Bruce C Cozadd | — | 2026年8月5日 A | 362,287 | 0 | 20 | $-25,646,326 |
| Ted W Love | — | 2026年8月5日 A | 3,132 | 0 | 0 | $0 |
| Norbert G Riedel | — | 2026年8月5日 A | 8,629 | 0 | 1 | $-655,680 |
| Kenneth W O'Keefe | — | 2025年12月2日 F | 25,811 | 0 | 0 | $0 |
| Daniel N Swisher JR | — | 2019年1月3日 F | 16,512 | 0 | 0 | $0 |
| Suzanne Sawochka Hooper | — | 2018年12月14日 M | 41,184 | 0 | 0 | $0 |
| Matthew P. Young | — | 2018年11月23日 S | 32,068 | 0 | 0 | $0 |
| MILLER MICHAEL PATRICK | — | 2018年11月13日 S | 24,972 | 0 | 0 | $0 |
| Paul Treacy | — | 2018年8月10日 S | 17,458 | 0 | 0 | $0 |
| Elmar Schnee | — | 2018年8月9日 A | 6,094 | 0 | 0 | $0 |
| Peter Gray | — | 2018年8月9日 A | 8,182 | 0 | 0 | $0 |
| Catherine A. Sohn | — | 2018年8月9日 A | 7,654 | 0 | 0 | $0 |
| Paul L Berns | — | 2018年8月9日 A | 6,772 | 0 | 0 | $0 |
| Karen J Wilson | — | 2018年5月11日 S | 15,757 | 0 | 0 | $0 |
| Karen L. Smith | — | 2018年3月5日 F | 28,474 | 0 | 0 | $0 |
| Iain Mcgill | — | 2018年3月5日 F | 22,048 | 0 | 0 | $0 |
| Russell J. Cox | — | 2017年3月6日 F | 52,795 | 0 | 0 | $0 |
| Jeffrey K Tobias | — | 2015年3月5日 F | 38,484 | 0 | 0 | $0 |
| Fintan Keegan | — | 2014年7月8日 M | 31,750 | 0 | 0 | $0 |
| Kathryn E Falberg | — | 2014年3月5日 F | 133,387 | 0 | 0 | $0 |
| James C Momtazee | — | 2013年8月13日 S | 17,315 | 0 | 0 | $0 |
| Carol A Gamble | — | 2012年3月9日 S | 32,213 | 0 | 0 | $0 |
| Alan Sebulsky | — | 2012年3月9日 S | 54,355 | 0 | 0 | $0 |
| Samuel D Colella | — | 2012年1月11日 M | 38,347 | 0 | 0 | $0 |
| Michael W Michelson | — | 2012年1月11日 M | 13,885 | 0 | 0 | $0 |
| Mark G. Eller | — | 2011年8月13日 M | 4,151 | 0 | 0 | $0 |
| Michael A. Desjardin | — | 2011年8月13日 M | 14,574 | 0 | 0 | $0 |
| Janne Lt Wissel | — | 2011年5月31日 J | 48,544 | 0 | 0 | $0 |
| Joan Colligan | — | 2010年11月30日 J | 14,424 | 0 | 0 | $0 |
| Robert M Myers | — | 2010年11月30日 J | 156,898 | 0 | 0 | $0 |
| James B Tananbaum | — | 2010年8月25日 A | 21,366 | 0 | 0 | $0 |
| Samuel R Saks | — | 2009年1月21日 A | 358,868 | 0 | 0 | $0 |
| Matthew K Fust | — | 2008年11月28日 J | 58,948 | 0 | 0 | $0 |
SECフォーム3/4/5提出書類からのインサイダー；純額＝公開市場のP/Sのみ
アクティビストおよび5%超のオーナー 6保有
SECスケジュール13Dを提出した投資家 — 発行体の影響を与える意図（アクティビストの保有、取締役会キャンペーン、M&A）を持つ5%超の受益権所有。各行は、その提出者のポジションの最新の既知の状態を示します。
| 提出者 | 提出済み | 保有 | ステータス | 目的 | 提出書類 |
|---|---|---|---|---|---|
| Jazz Pharmaceuticals Public Limited Company, Jazz Financing I Limited, Jazz Investments II Limited, Jazz Pharmaceuticals Italy S.p.A. ×4 提出書類 | 2014年6月20日 | — | 初回提出 | — | SEC |
| KKR JP LLC, KKR Millennium Fund L.P., KKR Associates Millennium L.P., KKR Millennium GP LLC, KKR Fund Holdings L.P., KKR Fund Holdings GP Limited, KKR Group Holdings L.P., KKR Group Limited, KKR & Co. L.P., KKR Management LLC, KKR JP III LLC, KKR Partners III, L.P., KKR III GP LLC, Henry R. Kravis, George R. Roberts ×3 提出書類 | 2013年3月12日 | — | 初回提出 | — | SEC |
| Longitude Capital Partners, LLC, Longitude Venture Partners, L.P., Longitude Capital Associates, L.P., Patrick G. Enright, Juliet Tammenoms Bakker ×3 提出書類 | 2012年3月14日 | — | 初回提出 | 資本構成 | SEC |
| Longitude Capital Partners, LLC (2), Longitude Venture Partners, L.P. (2), Longitude Capital Associates, L.P. (2), Patrick G. Enright (2), Juliet Tammenoms Bakker (2) ×3 提出書類 | 2011年9月30日 | — | 初回提出 | — | SEC |
| Azur Pharma Limited | 2011年9月28日 | — | 初回提出 | — | SEC |
| Jazz Pharmaceuticals, Inc., KKR Millennium Fund L.P., KKR Associates Millennium L.P., KKR Millennium GP LLC, KKR Partners III, L.P., KKR III GP LLC, KKR JP LLC, KKR JP III LLC | 2005年4月28日 | — | 初回提出 | M&A / 売却 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF保有状況 72のETFが保有
ウェイトは直接株式保有（N-PORT）のみを反映しています。レバレッジ型またはデリバティブベースのファンドは、表示されていない追加のスワップエクスポージャーを保有している可能性があります。
| ファンド | ウェイト | 単位 | 時点 | ソース |
|---|---|---|---|---|
| IHE · iShares Trust | 3.55% | 224,123 SH | 2026年8月8日 | 日次 |
| PJP · Invesco Exchange-Traded Fund Trust | 2.75% | 54,246 SH | 2026年8月8日 | 日次 |
| PTH · Invesco Exchange-Traded Fund Trust | 1.88% | 18,101 SH | 2026年8月8日 | 日次 |
| PILL · Direxion Shares ETF Trust | 1.47% | 931 NS | 2026年4月30日 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 1.10% | 3,412 SH | 2026年8月8日 | 日次 |
| RFG · Invesco Exchange-Traded Fund Trust | 1.01% | 14,167 SH | 2026年8月8日 | 日次 |
| IJK · iShares Trust | 0.86% | 367,117 SH | 2026年8月8日 | 日次 |
| IVOG · VANGUARD ADMIRAL FUNDS | 0.79% | 61,910 SH | 2026年8月8日 | 日次 |
| PDP · Invesco Exchange-Traded Fund Trust | 0.64% | 37,430 SH | 2026年8月8日 | 日次 |
| XJH · iShares Trust | 0.51% | 8,479 SH | 2026年8月8日 | 日次 |
| ISCV · iShares Trust | 0.50% | 13,756 SH | 2026年8月8日 | 日次 |
| LSVD · ADVISORS' INNER CIRCLE FUND | 0.50% | 14,803 NS | 2026年4月30日 | N-PORT |
| AVMV · AMERICAN CENTURY ETF TRUST | 0.49% | 12,809 NS | 2026年5月31日 | N-PORT |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0.48% | 8,322 SH | 2026年8月8日 | 日次 |
| IJH · iShares Trust | 0.44% | 2,164,793 SH | 2026年8月8日 | 日次 |
| SMMV · iShares Trust | 0.41% | 4,673 SH | 2026年8月8日 | 日次 |
| IVOO · VANGUARD ADMIRAL FUNDS | 0.41% | 101,353 SH | 2026年8月8日 | 日次 |
| VFVA · VANGUARD WELLINGTON FUND | 0.32% | 11,363 SH | 2026年8月8日 | 日次 |
| VBR · VANGUARD INDEX FUNDS | 0.31% | 867,777 SH | 2026年8月8日 | 日次 |
| AVLV · AMERICAN CENTURY ETF TRUST | 0.28% | 154,718 NS | 2026年5月31日 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0.28% | 8,083 SH | 2026年8月8日 | 日次 |
| IYH · iShares Trust | 0.25% | 35,721 SH | 2026年8月8日 | 日次 |
| ISCB · iShares Trust | 0.25% | 2,794 SH | 2026年8月8日 | 日次 |
| DFAS · Dimensional ETF Trust | 0.25% | 169,973 NS | 2026年4月30日 | N-PORT |
| MIDU · Direxion Shares ETF Trust | 0.24% | 1,006 NS | 2026年4月30日 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0.24% | 19,561 SH | 2026年8月8日 | 日次 |
| NUSC · Nushares ETF Trust | 0.23% | 14,796 NS | 2026年4月30日 | N-PORT |
| ESML · iShares Trust | 0.23% | 25,562 SH | 2026年8月8日 | 日次 |
| AVMC · AMERICAN CENTURY ETF TRUST | 0.20% | 3,508 NS | 2026年5月31日 | N-PORT |
| SMMD · iShares Trust | 0.20% | 29,882 SH | 2026年8月8日 | 日次 |
| VHT · VANGUARD WORLD FUND | 0.20% | 166,548 SH | 2026年8月8日 | 日次 |
| RWK · Invesco Exchange-Traded Fund Trust … | 0.20% | 10,307 SH | 2026年8月8日 | 日次 |
| VXF · VANGUARD INDEX FUNDS | 0.17% | 719,903 SH | 2026年8月8日 | 日次 |
| VB · VANGUARD INDEX FUNDS | 0.17% | 1,366,973 SH | 2026年8月8日 | 日次 |
| DFAT · Dimensional ETF Trust | 0.17% | 113,983 NS | 2026年4月30日 | N-PORT |
| DFSV · Dimensional ETF Trust | 0.16% | 59,597 NS | 2026年4月30日 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0.15% | 1,679 NS | 2026年5月31日 | N-PORT |
| IWS · iShares Trust | 0.15% | 89,654 SH | 2026年8月8日 | 日次 |
| AVIE · AMERICAN CENTURY ETF TRUST | 0.14% | 59 NS | 2026年5月31日 | N-PORT |
| WSML · iShares Trust | 0.13% | 3,473 SH | 2026年8月8日 | 日次 |
| AVSU · AMERICAN CENTURY ETF TRUST | 0.13% | 2,492 NS | 2026年5月31日 | N-PORT |
| IWR · iShares Trust | 0.11% | 243,081 SH | 2026年8月8日 | 日次 |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.10% | 3,276 SH | 2026年8月8日 | 日次 |
| XT · iShares Trust | 0.09% | 13,696 SH | 2026年8月8日 | 日次 |
| AVLC · AMERICAN CENTURY ETF TRUST | 0.08% | 4,239 NS | 2026年5月31日 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0.08% | 42,911 NS | 2026年5月31日 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.07% | 2,294 NS | 2026年5月31日 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.07% | 147,813 NS | 2026年4月30日 | N-PORT |
| DFUV · Dimensional ETF Trust | 0.06% | 45,962 NS | 2026年4月30日 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.05% | 7,081 NS | 2026年4月30日 | N-PORT |